The present disclosure is directed to methods of treating pancreatic cancer in subject using cancer with antibodies that specifically bind to progastrin.
申请公布号
SG182331(A1)
申请公布日期
2012.08.30
申请号
SG20120049136
申请日期
2011.01.07
申请人
BIOREALITES;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
